Retinografia como forma de rastreio de retinopatia diabética em hospital terciário do Sistema Único de Saúde

Q4 Medicine

Revista Brasileira De Oftalmologia Pub Date : 2022-01-01 DOI:10.37039/1982.8551.20220057

J. Bortoli, Paulo Caldas Silber, Egídio Picetti, Cássio Roberto Borges da Silva, H. M. Pakter

{"title":"Retinografia como forma de rastreio de retinopatia diabética em hospital terciário do Sistema Único de Saúde","authors":"J. Bortoli, Paulo Caldas Silber, Egídio Picetti, Cássio Roberto Borges da Silva, H. M. Pakter","doi":"10.37039/1982.8551.20220057","DOIUrl":null,"url":null,"abstract":"Objective: To evaluate the impact of diabetic retinopathy (DR) screening using color retinography in diabetic patients. Methods: Retrospective descriptive study, evaluating reports of all retinographs performed since the implementation of the protocol for screening for diabetic retinopathy in diabetic patients followed up at the endocrinology outpatient clinic of a tertiary hospital of the Unified Health System, from May 2018 to May 2020. Results: 727 diabetic with age range from 14 to 91 years old, the majority being 60 years old or older (53.2%), female (68%) and white (87.6%), patients underwent retinography. Of the patients, 467 (64.2%) did not have DR, 125 (17.2%) had non-proliferative DR, 37 (5.1%) had severe non-proliferative DR and/ or suspected macular edema, 65 (8.9%) had proliferative DR, 21 (2.9%) had suspicion signs of other pathologies and 12 (1.7%) had unsatisfactory images. A total of 114 (15.68%) patients were considered at high risk (those with severe non-proliferative NP and/or EM, proliferative DR or poor image) and were referred for comprehensive ophthalmic evaluation. Conclusion: The screening of RD with color retinography enabled the detection of high-risk diabetic patients who needed assistance sooner and enabled their access to ophthalmologic consultation, which decreased disease morbidity. The others were referred to primary care for regulation through the Regulation System (SISREG).","PeriodicalId":49619,"journal":{"name":"Revista Brasileira De Oftalmologia","volume":"17 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Brasileira De Oftalmologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37039/1982.8551.20220057","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To evaluate the impact of diabetic retinopathy (DR) screening using color retinography in diabetic patients. Methods: Retrospective descriptive study, evaluating reports of all retinographs performed since the implementation of the protocol for screening for diabetic retinopathy in diabetic patients followed up at the endocrinology outpatient clinic of a tertiary hospital of the Unified Health System, from May 2018 to May 2020. Results: 727 diabetic with age range from 14 to 91 years old, the majority being 60 years old or older (53.2%), female (68%) and white (87.6%), patients underwent retinography. Of the patients, 467 (64.2%) did not have DR, 125 (17.2%) had non-proliferative DR, 37 (5.1%) had severe non-proliferative DR and/ or suspected macular edema, 65 (8.9%) had proliferative DR, 21 (2.9%) had suspicion signs of other pathologies and 12 (1.7%) had unsatisfactory images. A total of 114 (15.68%) patients were considered at high risk (those with severe non-proliferative NP and/or EM, proliferative DR or poor image) and were referred for comprehensive ophthalmic evaluation. Conclusion: The screening of RD with color retinography enabled the detection of high-risk diabetic patients who needed assistance sooner and enabled their access to ophthalmologic consultation, which decreased disease morbidity. The others were referred to primary care for regulation through the Regulation System (SISREG).

查看原文本刊更多论文

在Sistema unico de saude的一家三级医院，视网膜造影作为糖尿病视网膜病变筛查的一种方法

目的:评价彩色视网膜造影在糖尿病视网膜病变(DR)筛查中的作用。方法:回顾性描述性研究，评估2018年5月至2020年5月在统一卫生系统某三级医院内分泌门诊随访的糖尿病患者实施糖尿病视网膜病变筛查方案以来的所有视网膜造影报告。结果:727例糖尿病患者行视网膜造影，年龄14 ~ 91岁，以60岁及以上为主(53.2%)，女性占68%，白人占87.6%。无DR 467例(64.2%)，非增殖性DR 125例(17.2%)，重度非增殖性DR 37例(5.1%)和/或疑似黄斑水肿，增殖性DR 65例(8.9%)，怀疑其他病理征象21例(2.9%)，影像不满意12例(1.7%)。114例(15.68%)患者被认为是高风险患者(严重的非增殖性NP和/或EM，增殖性DR或图像差)，并被转诊进行眼科综合评估。结论:彩色视网膜造影筛查RD可使需要帮助的糖尿病高危患者更早发现并获得眼科会诊，从而降低疾病发病率。其他人则通过监管系统(SISREG)提交初级保健监管。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Revista Brasileira De Oftalmologia OPHTHALMOLOGY-

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： A Revista Brasileira de Oftalmologia (Rev Bras Oftalmol.) - ISSN 0034-7280, publicação científica da Sociedade Brasileira de Oftalmologia, se propõe a divulgar artigos que contribuam para o aperfeiçoamento e o desenvolvimento da prática, da pesquisa e do ensino da Oftalmologia e de especialidades afins. Todos os manuscritos, após aprovação pelos Editores serão avaliados por dois ou três revisores qualificados (peer review), sendo o anonimato garantido em todo o processo de julgamento.